Ono Pharmaceuticals   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Osaka Japan (1717)

Organization Overview

First Clinical Trial
1996
NCT00212680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Clinical Department, Ono Pharmaceutical Co. Ltd | Clinical Development, ONO Pharma UK, Ltd | Ono Pharmaceutial Co., Ltd | ONO Pharmaceutical Co. | Ono Pharmaceutical Co. Ltd | Ono Pharmaceutical Co. LtTd. | Ono pharmaceutical Korea | Ono Pharma UK | Ono Pharma USA Inc